Turn this role into an interview — a resume and cover letter built around what this employer wants.
Revolution Medicines is seeking an experienced Nurse Case Manager (RNCM) to support patients prescribed Revolution Medicines therapies. The role is regionally aligned with a hybrid model, coordinating with insurers, providers, and a third-party HUB to navigate coverage and patient access programs.
You will work with a cross-functional team to ensure timely access, PA management, and escalation handling, aiming to minimize barriers for patients and streamline transitions from EAP programs after
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Nurse Case Manager (RNCM) role sits at the intersection of patient advocacy, insurance policy, and product access - making this a critical role in supporting patients who have been prescribed a Revolution Medicines therapy. The RNCM Team will operate in a hybrid model in close partnership with a third-party HUB responsible for intake, benefits investigation, and Customer Relationship Management (CRM) operations. RNCMs will work directly with patients, healthcare providers, insurers, field reimbursement team, and other key stakeholders to help patients understand their coverage, access the company’s patient support programs, and connect with external resources that help overcome access barriers.
This regionally aligned team (Northeast, Southeast, Central, and West) will manage the launch and ongoing lifecycle of Revolution Medicines approved therapies using a patient centric model.
This role requires a strategic, independent worker with deep expertise in oncology market access, clinical knowledge, and a passion for ensuring no patient is left behind.
The base pay salary range for this full-time position is listed below. Please note that base pay salary is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities. In addition, some positions may include eligibility to earn commissions/bonus based on company and/or individual performance.
Note: No amount of pay is considered to be wages or compensation until such amount is earned, vested, and determinable. The amount and availability of any bonus, commission, incentive, field kit benefits, or any other form of compensation and field kit benefits that are allocable to a particular employee remains in the Company's sole and absolute discretion unless and until paid and may be modified at the Company’s sole and absolute discretion, consistent with applicable law.
Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact privacy@revmed.com.
Base Pay Salary Range
$187,200 - $208,000 USD